Suchen
Drugs Made In America Acquisition II Ord Shs
DMIIZur Watchlist hinzufügen
10.175USD
-0.005-0.05%
Handelsschluss 10-19 16:00（ET）
648.15MMarktkapitalisierung
26.46KGV TTM
Über Drugs Made In America Acquisition II Ord Shs Unternehmen
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shs Profil
BörsenkürzelDMII
Name des UnternehmensDrugs Made In America Acquisition II Corp
IPO-datumSep 25, 2025
CEOStockwell (Lynn)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
Geschäftsjahresende- -
Addresse1 East Broward Boulevard
StadtFT LAUDERDALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33301
Telefon19548703099
Website
BörsenkürzelDMII
IPO-datumSep 25, 2025
CEOStockwell (Lynn)
Führungskräfte von Drugs Made In America Acquisition II Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Mr. Roger Bendelac
Mr. Roger Bendelac
Chief Executive Officer
Chief Executive Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Drugs Made In America Acquisition II Ord Shs?
Die fünf größten Anteilseigner von Drugs Made In America Acquisition II Ord Shs sind: Dr. Catherine Do